CFTR and pachyonychia congenita: Additionally, even CFTR mutation carriers had a higher risk of developing PC compared to non-carrier, which was reported in a large-scale meta-analysis that pooled 1674 PC patients versus 19,036 controls, which confirmed a statistically significant increased risk (OR = 1.41; 95% CI = 1.07–1.84) [174].